Cerebrospinal fluid neurogranin/β-site APP-cleaving enzyme 1 predicts cognitive decline in preclinical Alzheimer's disease.
Kirsebom BE, Nordengen K, Selnes P, Waterloo K, Torsetnes SB, Gísladóttir B, Brix B, Vanmechelen E, Bråthen G, Hessen E, Aarsland D, Fladby T.
Kirsebom BE, et al. Among authors: selnes p.
Alzheimers Dement (N Y). 2018 Nov 10;4:617-627. doi: 10.1016/j.trci.2018.10.003. eCollection 2018.
Alzheimers Dement (N Y). 2018.
PMID: 30519627
Free PMC article.